Article
Eukaryotic Translation Initiation Factor 5A Independently Predicts Poor Prognosis of…
Journal of Oncology · 2022 · Ping Wan, author Taiyuan Li, author Longfei Zhou, author Jun Zhang, author Xuefeng Rao, author Jinghua Pan, Academic Editor
Key facts
| Title | Eukaryotic Translation Initiation Factor 5A Independently Predicts Poor Prognosis of Cholangiocarcinoma Patients and Regulates the Ferroptosis and Mitochondrial Apoptosis |
|---|---|
| First author | Ping Wan, author Taiyuan Li, author Longfei Zhou, author Jun Zhang, author Xuefeng Rao, author Jinghua Pan, Academic Editor |
| Journal | Journal of Oncology |
| Published | May 6, 2022 |
| DOI | 10.1155/2022/4250531 |
| Devices mentioned | K190495, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 4 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DDG, JLX and 4 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1